Skip to main content
Livermore
Livermore
ZHEN

Blair William & Co

SEC CIK
0000902367
Latest filing
Aug 11, 2026

GALT holding history

Galectin Therapeutics Inc in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GALT overviewAll 13F holders of GALTFull Q2 2026 holdings

Shares (Q2 2026)
149,283
Value
$692.7K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of GALT by Blair William & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026149,283$692.7K<0.1%00.0%UnchangedHolders
Q1 2026149,283$416.5K<0.1%+111,399+294.1%AddedHolders
Q4 202537,884$157.6K<0.1%00.0%UnchangedHolders
Q3 202537,884$160.4K<0.1%00.0%UnchangedHolders
Q2 202537,884$79.9K<0.1%00.0%UnchangedHolders
Q1 202537,884$46.2K<0.1%00.0%UnchangedHolders
Q4 202437,884$48.9K<0.1%00.0%UnchangedHolders
Q3 202437,884$104.2K<0.1%00.0%UnchangedHolders
Q2 202437,884$85.6K<0.1%00.0%UnchangedHolders
Q1 202437,884$90.5K<0.1%00.0%UnchangedHolders
Q4 202337,884$62.9K<0.1%00.0%UnchangedHolders
Q3 202337,884$72.7K<0.1%00.0%UnchangedHolders
Q2 202337,884$54.6K<0.1%00.0%UnchangedHolders
Q1 202337,884$79.6K<0.1%00.0%UnchangedHolders
Q4 202237,884$42.8K<0.1%−3,000−7.3%ReducedHolders
Q3 202240,884$67.0K<0.1%00.0%UnchangedHolders
Q2 202240,884$54.0K<0.1%+40,884NewHolders
Q4 20210$00.0%−10,756−100.0%Sold outHolders
Q3 202110,756$42.0K<0.1%00.0%UnchangedHolders
Q2 202110,756$34.0K<0.1%00.0%UnchangedHolders
Q1 202110,756$23.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.